Roche Diagnostics Corporation C3d (Polyclonal) Pab, Cell Marque

Roche Diagnostics Corporation c3d (polyclonal; complement component c3 plays a central role in the activation of complement system. its activation is required for both classical and alternative complement activation pathways. c3d deposition in the renal transplant ptcs (peritubular capillaries) is indicative of ar (acute rejection) with subsequent high probability of graft loss. anti-c3d, combined with anti-c4d, can be utilized as a tool for diagnosis of ar and warrant prompt and aggressive anti-rejection treatment. - ROCHMSD (Additional S&H or Hazmat Fees May Apply)